SURGVISION

The Global Challenge Currently, the identification of tumours during surgery or interventional endoscopy relies on visual inspection and palpation. As tumour tissue is sometimes difficult to distinguish from healthy tissue surgical resection of tumour is incomplete in up to 40% of procedures 1. This has medical as well as financial implications, impairing patient treatment outcomes... The imaging agent BEVA800 TM labels cancer lesions in patients diagnosed with Barrett's Esophagus employing the EXPLORER FLUOSCOPE prototype (Nagengast et al. (2019) Gut 86:7-10)... A fluorescence imaging system for open surgical procedures EXPLORER AIR® II Cleared by the US FDA for ICG based perfusion imaging in February 2022

Registration numbers: HRB 261439 (W)

VAT numbers: DE 337761485

Primary location: Munich Germany